119 related articles for article (PubMed ID: 32908114)
1. Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy.
Utsunomiya M; Takahara M; Fujihara M; Shiraki T; Kozuki A; Fukunaga M; Tan M; Yoshioka R; Tomoi Y; Mori S; Iwasaki Y; Sasaki S; Nakamura M
J Atheroscler Thromb; 2021 Jun; 28(6):643-655. PubMed ID: 32908114
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
3. Retrograde Popliteal Access and Balloon Dilatation of Chronic Total Occlusion of Superficial Femoral Arteries.
Kuserli Y; Kavala AA
Ann Vasc Surg; 2020 Apr; 64():253-262. PubMed ID: 31634601
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease.
Scali ST; Rzucidlo EM; Bjerke AA; Stone DH; Walsh DB; Goodney PP; Chang CK; Powell RJ
J Vasc Surg; 2011 Sep; 54(3):714-21. PubMed ID: 21620611
[TBL] [Abstract][Full Text] [Related]
5. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
6. Does Metformin Have an Effect on Stent Patency Rates.
Kibrik P; Alsheekh A; Izakovich T; Chait J; Goldstein MA; Monteleone CM; Hingorani A; Ascher E
Vasc Endovascular Surg; 2019 Aug; 53(6):452-457. PubMed ID: 31170884
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Endovascular Treatment of Isolated Atherosclerotic Popliteal Artery Disease: Outcomes from the IPAD Multicenter Study.
Spiliopoulos S; Kitrou P; Galanakis N; Papadimatos P; Katsanos K; Konstantos C; Palialexis K; Reppas L; Kehagias E; Karnabatidis D; Brountzos E; Tsetis D
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1481-1487. PubMed ID: 29992345
[TBL] [Abstract][Full Text] [Related]
8. Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan.
Mori S; Hirano K; Yamauchi Y; Hayashi E; Doijiri T; Takamura T; Maeda A; Okuda J; Mizuno K; Onishi Y; Iwaki T; Tsukahara K; Shinozaki N; Araki H; Kongoji K; Sugano T; Miyamoto A; Michishita I
Heart Vessels; 2017 Sep; 32(9):1093-1098. PubMed ID: 28451834
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
[TBL] [Abstract][Full Text] [Related]
10. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries.
Dumantepe M
Vasc Endovascular Surg; 2017 Jul; 51(5):240-246. PubMed ID: 28595481
[TBL] [Abstract][Full Text] [Related]
11. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
12. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
15. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
16. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
20. Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery.
Itoga NK; Kim T; Sailer AM; Fleischmann D; Mell MW
J Vasc Surg; 2017 Sep; 66(3):835-843.e1. PubMed ID: 28502550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
